Asia-Pacific Laboratory Animal Diets Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Diet Type (Standard Diets, Irradiated Diets, and Autoclavable Diets), Animal (Mouse, Cat, Dog, Rabbit, Chicken, and Others), Application (Drug Discover

Asia-Pacific Laboratory Animal Diets Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Diet Type (Standard Diets, Irradiated Diets, and Autoclavable Diets), Animal (Mouse, Cat, Dog, Rabbit, Chicken, and Others), Application (Drug Discovery & Personalized Medicine, Regenerative Medicine, Pathology of Infectious Diseases, Drug Toxicity & Efficacy Testing, and Others), and End User (Pharmaceutical & Biopharmaceutical Companies, Research & Academic Institutes, and Others)

The laboratory animal diets market in APAC is expected to grow from US$ 486.55 million in 2022 to US$ 734.52 million by 2028; it is estimated to grow at a CAGR of 7.1% from 2022 to 2028.

Growing Inclination Toward Customized Diet Plan for Laboratory Animals to Bolster APAC Laboratory Animal Diets Market

Customized diets are fed to animals for controlling nutrients, inducing a disease, or using a dosing technique to treat the disease. Customized diets consist of refined ingredients which supply one major nutrient class such as casein, starches and sugar, fats and oils, and cellulose, and then micronutrients are added according to the requirement. The levels and types of nutrients and micronutrients are manipulated according to the necessity of the research purpose. For instance, if a zinc-deficient diet is required, the casein is replaced by egg white solids, as they are low in zinc. It is highly recommended that researchers using a custom diet for a new project must collaborate with a trusted nutritionist. These professionals can formulate diets with specific additions or deficiencies, including diets designed to mimic human dietary intakes. Sharing a researcher’s expertise on a particular research subject, coupled with the knowledge of nutrition, ingredients, and diet manufacturing, can make a custom diet a precision tool for creating experimental conditions that answer complex research questions. Due to the ongoing research on diseases such as metabolic diseases and cancer, the preference for a customized diet is increasing compared to a standardized diet.

Market Overview

The Asia Pacific laboratory animal diets market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. The region is witnessing an increasing number of world-leading mouse genetics research centers and facilities. Advances in genomic research have offered several benefits to the pharmaceutical industry owing to the use of animals in the vaccine discovery procedures that lead to the replacement of genetically-modified animals. The rising number of animal model applications in the healthcare domain in APAC would boost the market growth in the coming years. In addition, China has access to huge colonies of monkeys and other species. Thus, scientists in China face less public inspection than in Europe and the US. China has become the center of the CRISPR animal kingdom, which is appealing to the researchers, and the Chinese government has massively invested in new services and determined research projects. Animal research in the country is regulated and administratively managed according to the national and provincial laws, regulations, guidelines, and standards. Laboratory animal science in China has developed rapidly over the past 30 years due to the government and societal forces, which are encouraging the research projects in the country. In China, the People's Congress is the legislature; therefore, the National People's Congress and provincial People's Congresses approve and issue national and provincial laws, respectively. According to the Institute of Laboratory Animal Sciences (ILAS), China uses ~20 million animals, such as mice, dogs, rabbits, and nonhuman primates, in research each year. Thus, increasing biomedical research utilizing laboratory animals is expected to fuel the laboratory animal diet market during the forecast period.

APAC Laboratory Animal Diets Market Revenue and Forecast to 2028 (US$ Million)

APAC Laboratory Animal Diets Market Segmentation

The APAC laboratory animal diets market is segmented into diet type, animal, application, end user, and country.

Based on diet type, the market is segmented into standard diets, irradiated diets, and autoclavable diets. The standard diets segment registered the largest market share in 2022.

Based on animal, the APAC laboratory animal diets market is segmented into mouse, cat, dog, rabbit, chicken, and others. The mouse segment registered the largest market share in 2022.

Based on application, the APAC laboratory animal diets market is segmented into drug discovery and personalized medicines, regenerative medicines, pathology of infectious disease, drug toxicity and efficacy testing, and others. The drug discovery and personalized medicine segment registered the largest market share in 2022.

Based on end user, the APAC laboratory animal diets market is segmented into pharmaceutical & biopharmaceutical companies, research & academic institutes, and others. The pharmaceutical & biopharmaceutical companies segment registered the largest market share in 2022.

Based on country, the APAC laboratory animal diets market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. China dominated the market in 2022.

Altromin Spezialfutter GmbH & Co. KG, Bio-Serv, Envigo, Krishna Valley Agrotech LLP, LabDiet, Research Diets Inc., SAFE, Special Diet Services, and Specialty Feeds are the leading companies operating in the laboratory animal diets market in APAC.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe intravenous immunoglobulin market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe intravenous immunoglobulin market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the intravenous immunoglobulin market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution